Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Vaccines

  Free Subscription


17.09.2018

1 BMJ
5 Clin Infect Dis
1 J Infect Dis
1 J Pediatr
3 J Virol
1 Lancet Infect Dis
2 Pediatr Infect Dis J
3 PLoS One
3 Proc Natl Acad Sci U S A
1 Science
26 Vaccine
2 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMJ

  1. MURPHY DC
    Doctors who turn down flu vaccine could be redeployed.
    BMJ. 2018;362:k3872.
    PubMed     Text format    


    Clin Infect Dis

  2. COWLING BJ, Lim WW, Perera RAPM, Fang VJ, et al
    Influenza hemagglutination-inhibition antibody titer as a mediator of vaccine-induced protection for influenza B.
    Clin Infect Dis. 2018 Sep 8. pii: 5092748. doi: 10.1093.
    PubMed     Text format     Abstract available

  3. CHEN LH, Kozarsky PE, Visser LG
    What's old is new again: the re-emergence of yellow fever in Brazil and vaccine shortages.
    Clin Infect Dis. 2018 Sep 10. pii: 5094712. doi: 10.1093.
    PubMed     Text format     Abstract available

  4. LIPSITCH M
    Challenges of vaccine effectiveness and waning studies.
    Clin Infect Dis. 2018 Sep 10. pii: 5094713. doi: 10.1093.
    PubMed     Text format    

  5. FLANNERY B, Chung JR, Monto AS, Martin ET, et al
    Influenza Vaccine Effectiveness in the United States during the 2016-2017 Season.
    Clin Infect Dis. 2018 Sep 11. pii: 5094815. doi: 10.1093.
    PubMed     Text format     Abstract available

  6. RAY GT, Lewis N, Klein NP, Daley MF, et al
    Intra-season Waning of Influenza Vaccine Effectiveness.
    Clin Infect Dis. 2018 Sep 10. pii: 5094689. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Infect Dis

  7. ATMAR RL, Cramer JP, Baehner F, Han C, et al
    An exploratory study of the salivary IgA responses to one dose of a Norovirus VLP candidate vaccine in healthy adults.
    J Infect Dis. 2018 Sep 10. pii: 5094041. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Pediatr

  8. O'LEARY ST, Brewer SE, Pyrzanowski J, Barnard J, et al
    Timing of Information-Seeking about Infant Vaccines.
    J Pediatr. 2018 Sep 5. pii: S0022-3476(18)30951.
    PubMed     Text format     Abstract available


    J Virol

  9. FREI JC, Wirchnianski AS, Govero J, Vergnolle O, et al
    Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available

  10. PISSANI F, Schulte B, Eller MA, Schultz BT, et al
    Modulation of Vaccine-induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in Humans.
    J Virol. 2018 Sep 12. pii: JVI.01143-18. doi: 10.1128/JVI.01143.
    PubMed     Text format     Abstract available

  11. SIVAN G, Glushakow-Smith SG, Katsafanas GC, Americo JL, et al
    Human host-range restriction of the vaccinia virus C7/K1 double deletion mutant is mediated by an atypical mode of translation inhibition.
    J Virol. 2018 Sep 12. pii: JVI.01329-18. doi: 10.1128/JVI.01329.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  12. WILDER-SMITH A, Hombach J, Ferguson N, Selgelid M, et al
    Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine.
    Lancet Infect Dis. 2018 Sep 5. pii: S1473-3099(18)30494.
    PubMed     Text format     Abstract available


    Pediatr Infect Dis J

  13. SIGAUQUE B, Moiane B, Massora S, Pimenta F, et al
    Early Declines in Vaccine Type Pneumococcal Carriage in Children Less Than 5 Years Old After Introduction of 10-valent Pneumococcal Conjugate Vaccine in Mozambique.
    Pediatr Infect Dis J. 2018;37:1054-1060.
    PubMed     Text format     Abstract available

  14. FARNAES L, Coufal N, Spector SA
    Vaccine Strain Varicella Infection in an Infant with Previously Undiagnosed Perinatal Human Immunodeficiency Type-1 Infection.
    Pediatr Infect Dis J. 2018 Sep 7. doi: 10.1097/INF.0000000000002183.
    PubMed     Text format     Abstract available


    PLoS One

  15. LI J, Helal ZH, Karch CP, Mishra N, et al
    A self-adjuvanted nanoparticle based vaccine against infectious bronchitis virus.
    PLoS One. 2018;13:e0203771.
    PubMed     Text format     Abstract available

  16. HOWLADER DR, Koley H, Sinha R, Maiti S, et al
    Development of a novel S. Typhi and Paratyphi A outer membrane vesicles based bivalent vaccine against enteric fever.
    PLoS One. 2018;13:e0203631.
    PubMed     Text format     Abstract available

  17. BHAVANAM S, Rayat GR, Keelan M, Kunimoto D, et al
    Characterization of immune responses of human PBMCs infected with Mycobacterium tuberculosis H37Ra: Impact of donor declared BCG vaccination history on immune responses and M. tuberculosis growth.
    PLoS One. 2018;13:e0203822.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  18. ALEMAN F, Tzarum N, Kong L, Nagy K, et al
    Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors.
    Proc Natl Acad Sci U S A. 2018 Jun 28. pii: 1802378115.
    PubMed     Text format     Abstract available

  19. BOTTERMANN M, Foss S, van Tienen LM, Vaysburd M, et al
    TRIM21 mediates antibody inhibition of adenovirus-based gene delivery and vaccination.
    Proc Natl Acad Sci U S A. 2018 Sep 12. pii: 1806314115.
    PubMed     Text format     Abstract available

  20. HAABETH OAW, Blake TR, McKinlay CJ, Waymouth RM, et al
    mRNA vaccination with charge-altering releasable transporters elicits human T cell responses and cures established tumors in mice.
    Proc Natl Acad Sci U S A. 2018 Sep 10. pii: 1810002115.
    PubMed     Text format     Abstract available


    Science

  21. COHEN J
    Steep drop in Zika cases undermines vaccine trial.
    Science. 2018;361:1055-1056.
    PubMed     Text format    


    Vaccine

  22. WEI S, Lei Y, Yang J, Wang X, et al
    Neutralization effects of antibody elicited by chimeric HBV S antigen viral-like particles presenting HCV neutralization epitopes.
    Vaccine. 2018 Mar 22. pii: S0264-410X(18)30381.
    PubMed     Text format     Abstract available

  23. TANG X, Liu F, Sheng X, Xing J, et al
    Recombinant NADP-dependent isocitrate dehydrogenase of Edwardsiella tarda induces both Th1 and Th2 type immune responses and evokes protective efficacy against edwardsiellosis.
    Vaccine. 2018;36:2337-2345.
    PubMed     Text format     Abstract available

  24. SARKAR I, Garg R, van Drunen Littel-van den Hurk S
    The respiratory syncytial virus fusion protein formulated with a polymer-based adjuvant induces multiple signaling pathways in macrophages.
    Vaccine. 2018;36:2326-2336.
    PubMed     Text format     Abstract available

  25. SEGURA-CERDA CA, Aceves-Sanchez MJ, Marquina-Castillo B, Mata-Espinoza D, et al
    Immune response elicited by two rBCG strains devoid of genes involved in c-di-GMP metabolism affect protection versus challenge with M. tuberculosis strains of different virulence.
    Vaccine. 2018;36:2069-2078.
    PubMed     Text format     Abstract available

  26. VAEZIRAD MM, Koene MG, Wagenaar JA, van Putten JPM, et al
    Chicken immune response following in ovo delivery of bacterial flagellin.
    Vaccine. 2018;36:2139-2146.
    PubMed     Text format     Abstract available

  27. ISABEL S, Higgins RR, Peci A, Isabel MR, et al
    Rotavirus genotypes circulating in Ontario, Canada, before and after implementation of the rotavirus immunization program.
    Vaccine. 2018;36:2033-2040.
    PubMed     Text format     Abstract available

  28. HUSSAIN I, Mach O, Hamid NA, Bhatti ZS, et al
    Seroprevalence of anti-polio antibodies in children from polio high risk area of Afghanistan: A cross sectional survey 2017.
    Vaccine. 2018;36:1921-1924.
    PubMed     Text format     Abstract available

  29. GYE HJ, Oh MJ, Nishizawa T
    Lack of nervous necrosis virus (NNV) neutralizing antibodies in convalescent sevenband grouper Hyporthodus septemfasciatus after NNV infection.
    Vaccine. 2018;36:1863-1870.
    PubMed     Text format     Abstract available

  30. ZHENG M, Jiang J, Zhang X, Wang N, et al
    Characterization of capsid protein (p495) of hepatitis E virus expressed in Escherichia coli and assembling into particles in vitro.
    Vaccine. 2018 Mar 12. pii: S0264-410X(18)30341.
    PubMed     Text format     Abstract available

  31. GROOM HC, Irving SA, Koppolu P, Smith N, et al
    Uptake and safety of Hepatitis B vaccination during pregnancy: A Vaccine Safety Datalink study.
    Vaccine. 2018 Sep 4. pii: S0264-410X(18)31214.
    PubMed     Text format     Abstract available

  32. MOKADDAS EM, Shibl AM, Elgouhary A, Elsobky M, et al
    Effect of the introduction of pneumococcal conjugate vaccines on serotype prevalence in Kuwait and Saudi Arabia.
    Vaccine. 2018 Sep 5. pii: S0264-410X(18)31076.
    PubMed     Text format     Abstract available

  33. CHEN C, Beutels P, Wood J, Menzies R, et al
    Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia.
    Vaccine. 2018 Sep 10. pii: S0264-410X(18)31234.
    PubMed     Text format     Abstract available

  34. BARTHOLOMEUS E, De Neuter N, Meysman P, Suls A, et al
    Transcriptome profiling in blood before and after hepatitis B vaccination shows significant differences in gene expression between responders and non-responders.
    Vaccine. 2018 Sep 8. pii: S0264-410X(18)31236.
    PubMed     Text format     Abstract available

  35. THOMSON A, Vallee-Tourangeau G, Suggs LS
    Strategies to increase vaccine acceptance and uptake: From behavioral insights to context-specific, culturally-appropriate, evidence-based communications and interventions.
    Vaccine. 2018 Sep 7. pii: S0264-410X(18)31140.
    PubMed     Text format    

  36. ULENDORF JACOBSEN S, Valentiner-Branth P, Molbak K
    Examining determinants for reporting suspected adverse events following HPV vaccination in Denmark.
    Vaccine. 2018 Sep 7. pii: S0264-410X(18)31190.
    PubMed     Text format     Abstract available

  37. ZHANG C, Li LH, Wang J, Zhao Z, et al
    Enhanced protective immunity against spring viremia of carp virus infection can be induced by recombinant subunit vaccine conjugated to single-walled carbon nanotubes.
    Vaccine. 2018 Sep 7. pii: S0264-410X(18)31110.
    PubMed     Text format     Abstract available

  38. PNIEWSKI T, Milczarek M, Wojas-Turek J, Pajtasz-Piasecka E, et al
    Plant lyophilisate carrying S-HBsAg as an oral booster vaccine against HBV.
    Vaccine. 2018 Sep 6. pii: S0264-410X(18)31241.
    PubMed     Text format     Abstract available

  39. ALBANESE GA, Lee DH, Cheng IN, Hilt DA, et al
    Biological and molecular characterization of ArkGA: A novel Arkansas serotype vaccine that is highly attenuated, efficacious, and protective against homologous challenge.
    Vaccine. 2018 Sep 6. pii: S0264-410X(18)31228.
    PubMed     Text format     Abstract available

  40. BRANDON D, Kimmel M, Kuriyakose SO, Kostanyan L, et al
    Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults.
    Vaccine. 2018 Sep 6. pii: S0264-410X(18)31180.
    PubMed     Text format     Abstract available

  41. SU QD, He SH, Yi Y, Qiu F, et al
    Intranasal vaccination with ebola virus GP amino acids 258-601 protects mice against lethal challenge.
    Vaccine. 2018 Sep 5. pii: S0264-410X(18)31238.
    PubMed     Text format     Abstract available

  42. MATTHEWS I, Lu X, Dawson H, Bricout H, et al
    Assessing the effectiveness of zoster vaccine live: A retrospective cohort study using primary care data in the United Kingdom.
    Vaccine. 2018 Sep 5. pii: S0264-410X(18)31166.
    PubMed     Text format     Abstract available

  43. MUHSEN IN, Aljurf M, Wingard JR, Poland GA, et al
    Vaccinating donors for hematopoietic cell transplantation: A systematic review and future perspectives.
    Vaccine. 2018 Sep 5. pii: S0264-410X(18)31173.
    PubMed     Text format     Abstract available

  44. FISKER AB, Thysen SM
    Non-live pentavalent vaccines after live measles vaccine may increase mortality.
    Vaccine. 2018 Sep 5. pii: S0264-410X(18)31233.
    PubMed     Text format     Abstract available

  45. MCGRATH LJ, Layton JB, Krueger WS, Kshirsagar AV, et al
    High-dose influenza vaccine use among patients receiving hemodialysis in the United States, 2010-2013.
    Vaccine. 2018 Sep 5. pii: S0264-410X(18)31229.
    PubMed     Text format     Abstract available

  46. HORSINGTON J, Nfon C, Gonzales JL, Singanallur N, et al
    Protection in sheep against heterologous challenge with serotype Asia-1 foot-and-mouth disease virus using high potency vaccine.
    Vaccine. 2018 Sep 5. pii: S0264-410X(18)31213.
    PubMed     Text format     Abstract available

  47. MORGENSTERN K, Xie Y, Palladino G, Barr JR, et al
    Reference antigen-free and antibody-free LTD-IDMS assay for influenza H7N9 vaccine in vitro potency determination.
    Vaccine. 2018 Sep 4. pii: S0264-410X(18)31204.
    PubMed     Text format     Abstract available


    Virology

  48. KIM KH, Kwon YM, Lee YT, Hwang HS, et al
    Virus-like particles presenting flagellin exhibit unique adjuvant effects on eliciting T helper type 1 humoral and cellular immune responses to poor immunogenic influenza virus M2e protein vaccine.
    Virology. 2018;524:172-181.
    PubMed     Text format     Abstract available

  49. MURA M, Ruffie C, Billon-Denis E, Combredet C, et al
    hCD46 receptor is not required for measles vaccine Schwarz strain replication in vivo: Type-I IFN is the species barrier in mice.
    Virology. 2018;524:151-159.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: